Phase 3 Trials in Breast Cancer Prevention：Focus on Estrogen-Targeting Agents, Selective Estrogen Receptor Modulators and Aromatase Inhibitors

Barbara K. Dunn

Progress in Chemistry ›› 2013, Vol. 25 ›› Issue (09) : 1429-1449.

PDF(1697 KB)
中文
Earlier issues
Announcement
More
PDF(1697 KB)
Progress in Chemistry ›› 2013, Vol. 25 ›› Issue (09) : 1429-1449. DOI: 10.7536/PC130747

Phase 3 Trials in Breast Cancer Prevention：Focus on Estrogen-Targeting Agents, Selective Estrogen Receptor Modulators and Aromatase Inhibitors

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2013, 25(09): 1429-1449 https://doi.org/10.7536/PC130747

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1697 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉